Oral monitoring of a pediatric patient during chemotherapy treatment

Authors

  • Isabella Lima Arrais Ribeiro Departament of Statistic, Federal University of Paraiba, João Pessoa
  • Ana Maria Gondim Valença Department of Clinic and Social Dentistry, Federal University of Paraiba, João Pessoa
  • Paulo Rogério Ferreti Bonan Department of Clinic and Social Dentistry, Federal University of Paraiba, João Pessoa
  • Fabíola Galbiatti de Carvalho Carlo Department of Clinic and Social Dentistry, Federal University of Paraiba, João Pessoa

Keywords:

Hodgkin lymphoma, pediatric cancer, oral mucositis.

Abstract

Introduction: Oral side effects must be expected during cancer treatment on pediatric patients.  Monitoring side effects on oral cavity of antineoplastic therapy is desirable but sometimes performed without criteria.

Objective: The purpose of this article is to describe an oral monitoring in an male with Hodgkin lymphoma during chemotherapy treatment using an Oral Assessment Guide.

Main data of case: An 11-yr-old male was assisted during all treatment of chemotherapy against Hodgkin's lymphoma in the dental sector of a hospital of reference of João Pessoa, Paraíba, Brazil. The Oral Assessment Guide was applied by a calibrate examiner and was observed the emergence of  ulcerative lesions on the labial mucosa emerged on two different periods (D15- primary cycle; D15-second cycle) and the major values of oral mucositis were verified in  D1 e D15 periods of second cycle of chemotherapy.

Main comments: Monitoring oral side effects during antineoplastic therapy could prevent severe oral complications and avoid to associate systemic complications.

Downloads

Download data is not yet available.

Downloads

Published

2015-01-23

How to Cite

1.
Arrais Ribeiro IL, Gondim Valença AM, Ferreti Bonan PR, de Carvalho Carlo FG. Oral monitoring of a pediatric patient during chemotherapy treatment. Rev Cubana Estomatol [Internet]. 2015 Jan. 23 [cited 2025 Mar. 12];52(2):62-5. Available from: https://revestomatologia.sld.cu/index.php/est/article/view/518

Issue

Vol. 52 No. 2 (2015): APR- JUN

Section

Case Report

License

Authors retain all rights to their works, which they can reproduce and distribute as long as they cite the primary source of publication.

The Rev Cubana Estomatol is subject to the Creative Commons Attribution-Non-Commercial 4.0 International License (CC BY-NC 4.0) and follows the publication model of SciELO Publishing Schema (SciELO PS) for publication in XML format.

You are free to:

  • Share — copy and redistribute the material in any medium or format.
  • Adapt — remix, transform, and build upon the material.

The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

  • You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
  • No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.